(Total Views: 297)
Posted On: 08/03/2017 10:10:56 AM
Post# of 1458
Nice find. So their next study is going to address the safety concerns?
I think it was a mistake to have that arm that combined this drug with memantine. Memantine doesn't work all that well and has side effects of its own, and trying a new drug in combination with it -- which may have some kind of horrible interaction -- seems like a mistake.
It looks like this vTv company is not publicly traded. Is that correct?
Also -- for anyone wondering, it's perfectly fine to talk about Alzheimers' research companies other than AVXL. Our rules here about discussing other companies are much looser than other message boards.
I think it was a mistake to have that arm that combined this drug with memantine. Memantine doesn't work all that well and has side effects of its own, and trying a new drug in combination with it -- which may have some kind of horrible interaction -- seems like a mistake.
It looks like this vTv company is not publicly traded. Is that correct?
Also -- for anyone wondering, it's perfectly fine to talk about Alzheimers' research companies other than AVXL. Our rules here about discussing other companies are much looser than other message boards.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)